NCT03155854 The Effects of Prophylactic Limited Palmar Fasciectomy on Surgical Outcomes and Scarring
| NCT ID | NCT03155854 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Dupuytren Contracture |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2016-09 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2016-09 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Research is instrumental for improving medical care and the patient experience. Finding new surgical techniques can create better outcomes and minimize recovery time and complications for patients. Some patients undergoing trigger finger surgery with a pre-existing Dupuytren's cord may develop a thickened surgical scar after surgery, which can cause discomfort, difficulty with moving or using, and other complications in the affected finger(s) or hand. The investigator is investigating a surgical technique to minimize these potential complications and scarring after surgery. Subjects are being asked to take part in this research study because they have been diagnosed with trigger finger and pretendinous Dupuytren's cord and have decided to undergo surgery rather than try medical treatment.
Eligibility Criteria
Inclusion Criteria: * Potential candidates for the study will be selected based upon clinical diagnosis of trigger finger with co-existing pretendinous cord. All potential subjects will have either failed non operative treatment or elected surgical treatment. Exclusion Criteria: * \<18 years of age
Contact & Investigator
Sanjeev Kakar, MD
✉ Kakar.Sanjeev@mayo.eduSanjeev Kakar, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT03155854 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dupuytren Contracture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03155854 currently recruiting?
Yes, NCT03155854 is actively recruiting participants. Contact the research team at Kakar.Sanjeev@mayo.edu for enrollment information.
Where is the NCT03155854 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT03155854 clinical trial?
NCT03155854 is sponsored by Mayo Clinic. The principal investigator is Sanjeev Kakar, MD at Mayo Clinic. The trial plans to enroll 50 participants.